Sodium-Glucose Cotransporter-2 Inhibitors and Arrhythmias

Vikash Jaiswal; Song Peng Ang; Danisha Kumar; Novonil Deb; Akash Jaiswal; Amey Joshi; Yusra Nasir; Dhrubajyoti Bandyopadhyay; Erin D. Michos; Emelia Benjamin; Gregg C. Fonarow

doi:10.1016/j.jacadv.2025.101615

Abstract

1 min read

SGLT2i therapy was associated with an overall lower risk of atrial arrythmia and SCD in patients with type 2 diabetes mellitus and/or HF or chronic kidney disease. However, SGLT2i therapy was not associated with a lower risk of ventricular arrhythmia.

Related publications

Article2021

Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials

Dimitrios Sfairopoulos, Nan Zhang, Yueying Wang, Ziliang Chen, Κonstantinos P. Letsas, Gary Tse, Guangping Li, Professor Gregory Lip, Tong Liu, Panagiotis Korantzopoulos

Article2021

Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis

Nan Zhang, Yueying Wang, Gary Tse, Panagiotis Korantzopoulos, Κonstantinos P. Letsas, Qingpeng Zhang, Guangping Li, Professor Gregory Lip, Tong Liu

Article2017

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study

Tze‐Fan Chao, Chia‐Jen Liu, Ta‐Chuan Tuan, Su-Jung Chen, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2021

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

Hang‐Long Li, Professor Gregory Lip, Qi Feng, Yue Fei, Yi-Kei Tse, Mei-zhen Wu, Qing-Wen Ren, Hung‐Fat Tse, Bernard-M. Y. Cheung, Kai‐Hang Yiu

Article2023

New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase 4 inhibitors: A Chinese population-based cohort study

Xianchun Gao, Nong Zhang, Tianxiang Gao, Gary Tse, Professor Gregory Lip, Tong Liu, Jiandong Zhou

Sodium-Glucose Cotransporter-2 Inhibitors and Arrhythmias

Abstract

Discussion(0)

Related publications

Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials

Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis

New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase 4 inhibitors: A Chinese population-based cohort study